Latest research on Dexmethylphenidate

Dexmethylphenidate is the dextrorotary form of methylphenidate. It is a norepinephrine-dopamine reuptake inhibitor (NDRI) and thus a psychostimulant. It is used for treatment of Attention Deficit Hyperactivity Disorder (ADHD).

Dexmethylphenidate interactions

The analytes d-threo-methylphenidate and l-threo-methylphenidate and their internal standard methylphenidate-d9 were extracted from a 0.200 mL aliquot of human EDTA K2 plasma using an automated liquid–liquid extraction. [source, 2015]
Pharmacological measures that have shown potential include the psycho-stimulants Methylphenidate, DexMethylphenidate, erythropoietin, darbepoetin, progestational steroids (Medroxyprogesterone acetate, Megestrol Acetate), Modafinil, and Paroxetine [1,7]. [source, 2015]
The medications included were the ones currently approved by the FDA for the treatment of ADHD: Amphetamine, Atomoxetine, Clonidine, Dexmethylphenidate, dextroAmphetamine, Guanfacine, Lisdexamfetamine, methAmphetamine, and methylphenidate. [source, 2015]
Collectively, these medications included Amitriptyline, Atomoxetine, Baclofen, Citalopram, Clonidine, Dexmethylphenidate, esCitalopram, Guanfacine, Melatonin, methylphenidate, Pimozide, Quetiapine, Risperidone and Sertraline. [source, 2015]
Thirteen children in the ASD group were on psychotropic medication, including psychostimulants (Vyvanse, Adderall, Focalin), atypical antidepressants (Bupropion), antihypertensives/central alpha-2 adrenergic agonists (Tenex, Clonidine, Intuniv), benzodiazepines (Klonopin), selective serotonin reuptake inhibitors (SSRIs) (Prozac, Zoloft), mood stabilizers (Depakote), and atypical antipsychotics (Risperdal, Abilify). [source, 2015]
atomoxetine (Strattera), methylphenidate (Focalin, Daytrana, and others). [source, 2014]
In the USA a wide range of pharmacological treatments are approved for use in adults, including Atomoxetine (ATX), Methylphenidate (MPH), DexMethylphenidate, and various amphetamines (Castells et al., 2011; Fredriksen et al., 2013). [source, 2014]
These include extended-release Dexmethylphenidate, transdermal methylphenidate, osmotic-release oral system methylphenidate, extended-release mixed Amphetamine salts, Lisdexamfetamine, and the nonstimulants Atomoxetine, extended-release Guanfacine, and extended-release Clonidine. [source, 2014]
These were the stimulants Amphetamine, Dexmethylphenidate, dextroAmphetamine, Lisdexamfetamine, methAmphetamine, and methylphenidate, and the non-stimulants Atomoxetine, Clonidine, and Guanfacine. [source, 2014]
Ritalin LA® and Focalin XR® (both Novartis Pharmaceutical Corporation, East Hanover, New Jersey, USA) use Spheroidal Oral Drug Absorption System (SODAS®) technology to provide 50% of the MPH dose immediately and 50% as extended release [6,7]. [source, 2013]